ReviewImmuno-oncology technology2019

Driving innovation for rare skin cancers: utilizing common tumours and machine learning to predict immune checkpoint inhibitor response.

J S Hooiveld-Noeken et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.